Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Patient Advocacy & Government Affairs Intern will support Ardelyx’s corporate presence and relationship‑building efforts by helping to plan and execute a policy roundtable event that brings together state policymakers and advocates in addition to assisting with advocacy campaigns with internal and external stakeholders to elevate the voice of patients with IBS-C and CKD Reporting to the Patient Advocacy and Government Affairs team in Waltham, the intern will work on communications, event logistics, and stakeholder engagement activities that are central to the company’s government affairs and patient advocacy strategies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern
Education Level
No Education Listed